LIGAND PHARMACEUTICALS INCORPORATED (LGND) Operating margin 2016–2025
LIGAND PHARMACEUTICALS INCORPORATED (LGND) operating margin by fiscal year — reported operating income divided by reported revenue.
15.3%FY2025 · since FY2016: 40.3% → 15.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 15.3% | +28.8 pp |
| FY2024 | -13.5% | -22.6 pp |
| FY2023 | 9.1% | +7.5 pp |
| FY2022 | 1.5% | -41.4 pp |
| FY2021 | 43.0% | +20.1 pp |
| FY2020 | 22.9% | -648.1 pp |
| FY2019 | 671.0% | +605.9 pp |
| FY2018 | 65.1% | +16.9 pp |
| FY2017 | 48.2% | +8.0 pp |
| FY2016 | 40.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice